BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1595 related articles for article (PubMed ID: 33536322)

  • 21. Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals.
    Grosenbach DW; Hruby DE
    Methods Mol Biol; 2019; 2023():143-155. PubMed ID: 31240676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
    Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
    Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of
    Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
    Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques.
    Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE
    J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.
    Duraffour S; Andrei G; Snoeck R
    IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
    Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teaching a new mouse old tricks: Humanized mice as an infection model for Variola virus.
    Hutson CL; Kondas AV; Ritter JM; Reed Z; Ostergaard SD; Morgan CN; Gallardo-Romero N; Tansey C; Mauldin MR; Salzer JS; Hughes CM; Goldsmith CS; Carroll D; Olson VA
    PLoS Pathog; 2021 Sep; 17(9):e1009633. PubMed ID: 34547055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate.
    Warner BM; Klassen L; Sloan A; Deschambault Y; Soule G; Banadyga L; Cao J; Strong JE; Kobasa D; Safronetz D
    Sci Transl Med; 2022 Nov; 14(673):eade7646. PubMed ID: 36318038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pandemic potential of poxviruses: From an ancient killer causing smallpox to the surge of monkeypox.
    Brüssow H
    Microb Biotechnol; 2023 Sep; 16(9):1723-1735. PubMed ID: 37335284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro efficacy of ST246 against smallpox and monkeypox.
    Smith SK; Olson VA; Karem KL; Jordan R; Hruby DE; Damon IK
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1007-12. PubMed ID: 19075062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK
    Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.
    Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.
    Zaitseva M; McCullough KT; Cruz S; Thomas A; Diaz CG; Keilholz L; Grossi IM; Trost LC; Golding H
    J Virol; 2015 Mar; 89(6):3295-307. PubMed ID: 25589648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox.
    Gallardo-Romero NF; Hutson CL; Carroll D; Kondas AV; Salzer JS; Dietz-Ostergaard S; Smith S; Hudson P; Olson V; Damon I
    Virus Res; 2020 Jan; 275():197772. PubMed ID: 31593747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.
    Realegeno S; Puschnik AS; Kumar A; Goldsmith C; Burgado J; Sambhara S; Olson VA; Carroll D; Damon I; Hirata T; Kinoshita T; Carette JE; Satheshkumar PS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331092
    [No Abstract]   [Full Text] [Related]  

  • 37. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
    Alvarez-Cardona JJ; Whited LK; Chemaly RF
    Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New effective chemically synthesized anti-smallpox compound NIOCH-14.
    Mazurkov OY; Kabanov AS; Shishkina LN; Sergeev AA; Skarnovich MO; Bormotov NI; Skarnovich MA; Ovchinnikova AS; Titova KA; Galahova DO; Bulychev LE; Sergeev AA; Taranov OS; Selivanov BA; Tikhonov AY; Zavjalov EL; Agafonov AP; Sergeev AN
    J Gen Virol; 2016 May; 97(5):1229-1239. PubMed ID: 26861777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus.
    Schultz DA; Sagartz JE; Huso DL; Buller RM
    Virology; 2009 Jan; 383(1):86-92. PubMed ID: 18977501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monkeypox disease transmission in an experimental setting: prairie dog animal model.
    Hutson CL; Carroll DS; Gallardo-Romero N; Weiss S; Clemmons C; Hughes CM; Salzer JS; Olson VA; Abel J; Karem KL; Damon IK
    PLoS One; 2011; 6(12):e28295. PubMed ID: 22164263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.